SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 83 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2013. The put-call ratio across all filers is 0.12 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $526,000 | -44.6% | 2,021,728 | +313.4% | 0.01% | -25.0% |
Q1 2015 | $949,000 | -28.4% | 489,053 | -2.2% | 0.01% | -42.9% |
Q4 2014 | $1,325,000 | -12.0% | 500,000 | 0.0% | 0.01% | -26.3% |
Q3 2014 | $1,505,000 | -26.4% | 500,000 | 0.0% | 0.02% | -24.0% |
Q2 2014 | $2,045,000 | -5.1% | 500,000 | 0.0% | 0.02% | -7.4% |
Q1 2014 | $2,155,000 | -17.7% | 500,000 | 0.0% | 0.03% | -27.0% |
Q4 2013 | $2,620,000 | -17.0% | 500,000 | 0.0% | 0.04% | -17.8% |
Q3 2013 | $3,155,000 | -54.8% | 500,000 | -64.3% | 0.04% | -67.4% |
Q2 2013 | $6,981,000 | – | 1,399,040 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 37,069,140 | $64,500,000 | 87.00% |
ARMISTICE CAPITAL, LLC | 2,000,000 | $3,480,000 | 1.19% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 432,259 | $752,000 | 0.28% |
Geller Advisors LLC | 187,323 | $326,000 | 0.21% |
CAXTON CORP | 57,000 | $99,000 | 0.13% |
Verity Asset Management, Inc. | 64,476 | $112,000 | 0.11% |
TFS CAPITAL LLC | 367,364 | $639,000 | 0.06% |
Cutler Capital Management, LLC | 72,500 | $126,000 | 0.06% |
LUCAS CAPITAL MANAGEMENT | 21,100 | $37,000 | 0.02% |
Nine Chapters Capital Management LLC | 129,700 | $226,000 | 0.02% |